SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
154.40    1.60 (1.05%)
Bid:
154.40
Ask:
154.80
Spread: 0.40 (0.259%)
Market Cap: £883.65m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Q3 Trading Update

28 Oct 2020 07:00

RNS Number : 3962D
Elementis PLC
28 October 2020
 

Elementis plc

Q3 Trading Update

Resilient performance, in line with management expectations

On track for significant year end net debt reduction

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues a trading update for the three months ended 30 September 2020.

Third quarter business performance

 

While trading improved versus the second quarter, COVID-19 continues to impact the Group with volumes down approximately 13% on the prior year. Pricing remained resilient across all businesses except for Chromium. As a result of cost savings and supply chain efficiencies, overall performance in the third quarter was in line with management expectations.

· Coatings performed well in Q3, with revenue broadly in line with the prior year period, as continued resilience in decorative applications was supported by improved industrial demand. The business remains on track for improved operating margins versus the prior year.

 

· Personal Care sales were materially lower than both the prior year period and Q2, particularly in higher margin cosmetics, due to the continuation of social and travel restrictions as a result of COVID-19.

 

· Talc volumes recovered from the Q2 trough but as expected were below prior year. Automotive demand sequentially improved and coatings gained market share.

· Chromium performance was in line with Q2 levels, but materially down on the prior year period, reflective of lower demand at key customers and sustained industry pricing pressure, particularly in the rest of the world. Current Q4 trading indicates some recovery versus a difficult Q3.

 

· Energy continues to experience very weak market conditions with rig counts and activity levels remaining at subdued Q2 levels.

 

In the third quarter we have continued to successfully deliver against our Innovation, Growth and Efficiency strategy. We launched 3 new products, delivered $9m of new business and remain on track for delivery of $15m in year cost savings.

For 2021, our new business and innovation pipelines are encouraging, and we have made good progress underpinning $10m of supply chain cost efficiencies. Our new AP Actives plant in India remains on track for mid-2021 start up.

Liquidity and balance sheet

 

Elementis has a proven cash generative business model, with average operating cash conversion above 90% over the last 3 years and the Group is on track to deliver a significant reduction in net debt by year end.

 

The Group continues to operate with ample liquidity, with over $300m immediately available through committed lending facilities. As announced in September, the relaxation of the Group net debt/EBITDA* banking covenant to 3.75x, agreed in Q1 2020 as part of the Group's response to COVID19, has now been extended, at minimal cost, to include the two testing points in 2021 (i.e. 30 June and 31 December).

 

Outlook

 

Whilst market conditions remain challenging and future visibility is limited, we have seen solid demand in October and have a robust order book for November. We have a clear, focused strategy and we continue to tightly manage the business in terms of fixed costs and working capital to address changes in demand. An action plan to improve the financial performance of Energy is underway.

 

 

Commenting on the performance, CEO, Paul Waterman said,

"Overall performance has been resilient and in line with our expectations. Nevertheless, the macroeconomic outlook remains uncertain and our focus remains on managing our operations well and executing our growth, innovation and efficiency agenda.

In recent years we have focused Elementis on high quality, high margin activities in Personal Care, Coatings and Talc as these businesses have enduring positions of strength in structural growth markets. I am confident we will emerge from this crisis well positioned for improved top and bottom line performance and future value creation."

 

Enquiries

Elementis plc

James Curran, Investor Relations Tel: 020 7067 2994

 

Tulchan

Martin Robinson Tel: 020 7353 4200

David Allchurch

 

 

Note: * Pre IFRS 16

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMRBRTMTITBJM
Date   Source Headline
11th Jul 20255:32 pmRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20256:04 pmRNSTransaction in Own Shares
8th Jul 20255:27 pmRNSTransaction in Own Shares
7th Jul 20255:54 pmRNSTransaction in Own Shares
4th Jul 20255:30 pmRNSTransaction in Own Shares
3rd Jul 20256:05 pmRNSTransaction in Own Shares
2nd Jul 20255:49 pmRNSTransaction in Own Shares
1st Jul 20255:42 pmRNSTransaction in Own Shares
30th Jun 20256:02 pmRNSTransaction in Own Shares
27th Jun 20255:51 pmRNSTransaction in Own Shares
26th Jun 20255:55 pmRNSTransaction in Own Shares
25th Jun 20255:49 pmRNSTransaction in Own Shares
24th Jun 20255:52 pmRNSTransaction in Own Shares
23rd Jun 20255:31 pmRNSTransaction in Own Shares
20th Jun 20256:22 pmRNSTransaction in Own Shares
18th Jun 20256:06 pmRNSTransaction in Own Shares
17th Jun 20255:43 pmRNSTransaction in Own Shares
16th Jun 20256:07 pmRNSTransaction in Own Shares
13th Jun 20255:53 pmRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20255:38 pmRNSTransaction in Own Shares
10th Jun 20255:33 pmRNSTransaction in Own Shares
10th Jun 20253:49 pmRNSDirector/PDMR Shareholding
10th Jun 20253:48 pmRNSDirector/PDMR Shareholding
9th Jun 20256:19 pmRNSTransaction in Own Shares
6th Jun 20255:10 pmRNSTransaction in Own Shares
5th Jun 20255:54 pmRNSTransaction in Own Shares
4th Jun 20255:56 pmRNSTransaction in Own Shares
3rd Jun 20255:55 pmRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNSDirector/PDMR Shareholding
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSCommencement of Share Buyback
27th May 20257:00 amRNSSale of Talc business and intended buyback launch
7th May 20254:55 pmRNSHolding(s) in Company
1st May 202510:20 amRNSTotal Voting Rights
29th Apr 202512:24 pmRNSResult of AGM
29th Apr 20257:00 amRNSFirst quarter trading update
25th Mar 20254:22 pmRNSAnnual Financial Report & Notice of AGM
18th Mar 20254:22 pmRNSHolding(s) in Company
18th Mar 20253:10 pmRNSAdditional Listing
13th Mar 20257:00 amRNSAppointment of new Chief Executive Officer
6th Mar 20257:00 amRNSPreliminary results year ended 31 December 2024
3rd Mar 20259:41 amRNSBlock listing Interim Review
3rd Mar 20259:31 amRNSTotal Voting Rights
3rd Feb 20259:53 amRNSTotal Voting Rights
21st Jan 20257:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.